SOM Biotech at European Conference on Recent Advances in Lysosomal Diseases

posted on November 4, 2019

Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK.

The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the lysosomal storage in the cells, which contribute to the development of some of the main orphan diseases, as the Gaucher, the Fary, the Pompe, and the Hunter Syndromes. Knowledge about Lysosomal Diseases obtained at the conference will serve to SOM Biotech for the further advancement of its projects in this area.